Prescription Drug Affordability Boards: Strategic Framework for Market Access

As state Prescription Drug Affordability Boards (PDABs) gain momentum across the US, pharmaceutical stakeholders face new challenges in pricing strategy and market access.

Our latest white paper examines the varying powers of these boards, current legal challenges, and potential impacts on the industry landscape. This analysis provides valuable context for organizations navigating this evolving policy environment."